Dr. Victoria Dokic is currently Head of Science at FSHD Global Research Foundation. Her main role entails managing and overseeing all scientific activities of the Foundation, including actively seeking partnerships opportunities with researchers to find a treatment and cure for FSHD.
Victoria has been involved in research and pharmaceuticals for nearly 15 years’ and holds a PhD in Cardiovascular Medicine. She has also been involved in several entrepreneurial ventures, including winning $100,000 in the University of Queensland Enterprize Business Plan Competition. For several years. Victoria worked in the Medical Affairs division for large multinational companies AstraZeneca and Bayer and helped facilitate research and medical educations activities in the Cardiology and Thrombosis therapeutic areas. Her passion is to improve patient care and outcomes through research and innovation. Victoria regularly attends research conference, pharmaceutical networking events, has a keen interest in start-up companies. She was also a semi-finalist for both the South Australian Young Achiever of the Year and the SA Community Achievement Awards.